ESLAW logo

Estrella Immunopharma (ESLAW)

Profile

Full Name

Estrella Immunopharma, Inc.

Ticker Symbol

ESLAW

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.estrellabio.com

Employees

-

Key Details

Price

$0.05(+31.58%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.05
    ESLAW price is $0.05

    30-Day Relative Volume

    0.01
    ESLAW 30-day relative volume is 0.01

    Price Performance

    Price Most recent change

    +31.58%
    ESLAW price was up +31.58% on Jun 27, 2025

    Price YTD change

    -48.31%
    ESLAW price is down -48.31% since January 1st

    Price 1-year change

    -40.03%
    ESLAW price is down -40.03% year-on-year

    Price 3-year change

    -
    ESLAW price 3-year change is unknown

    Price Range

    Price All-time high

    $0.19
    ESLAW price is currently -75.13% below its historical high of $0.19

    Price 3-year low

    $0.03
    ESLAW price is currently +55.74% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    ESLAW market capitalization value is unknown

    Market cap 3-year change

    -
    ESLAW market capitalization 3-year change is unknown

    Market cap All-time high

    -
    ESLAW market capitalization all-time high is unknown

    Market cap sector rank

    -
    ESLAW market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    ESLAW shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    ESLAW shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.46
    ESLAW beta is 2.46

    200-day SMA

    $0.07
    ESLAW price is currently -34.21% below its 200-day simple moving average

    50-day SMA

    $0.07
    ESLAW price is currently -28.79% below its 50-day simple moving average

    RSI

    48.44
    ESLAW 14-day relative strength index is 48.44

    Volume

    0.01
    ESLAW 30-day relative volume is 0.01

    ATR

    $0.01
    ESLAW average true range is $0.01

    10-day Historical Volatility

    329.93%
    ESLAW 10-day historical volatility is 329.93%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ESLAW annual revenue is $0.00

    Revenue Analysts estimate

    -
    ESLAW annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ESLAW {parameterFullLabel} has remained unchanged year-on-year

    Revenue Sector rank

    -
    ESLAW annual revenue is unknown

    EPS

    EPS

    -
    ESLAW annual earnings per share value is unknown

    EPS Analysts estimate

    -
    ESLAW annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    ESLAW annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    ESLAW annual earnings per share is unknown

    Profit

    Gross profit

    -
    ESLAW annual gross profit value is unknown

    Gross margin

    -
    ESLAW annual gross profit margin value is unknown

    Operating profit

    -$7.31M
    ESLAW annual operating income is -$7.31 million

    Operating margin

    -
    ESLAW annual operating profit margin value is unknown

    Net income

    -$7.31M
    ESLAW annual net profit is -$7.31 million

    Net margin

    -
    ESLAW annual net profit margin value is unknown

    Expenses

    Total expenses

    $7.31M
    ESLAW annual total expenses is $7.31 million

    Operating expenses

    $7.31M
    ESLAW annual total operating expenses is $7.31 million

    Cost of goods sold

    -
    ESLAW annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $3.20M
    ESLAW annual SGA is $3.20 million

    Depreciation and amortization

    -
    ESLAW annual depreciation & amortization value is unknown

    Interest expense

    -
    ESLAW annual interest expense value is unknown

    Income tax

    $1625.00
    ESLAW annual income tax is $1625.00

    EBIT & EBITDA

    EBIT

    -$7.31M
    ESLAW annual earnings before interest & taxes is -$7.31 million

    EBITDA

    -$7.31M
    ESLAW annual EBITDA is -$7.31 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.45M
    ESLAW annual total assets is $4.45 million

    Non current assets

    $0.00
    ESLAW annual long term assets is $0.00

    Current assets

    $4.45M
    ESLAW annual total current assets is $4.45 million

    Cash and cash equivalents

    $4.17M
    ESLAW annual cash & cash equivalents is $4.17 million

    Accounts receivable

    -
    ESLAW annual accounts receivable value is unknown

    Inventory

    -
    ESLAW annual inventory value is unknown

    Liabilities

    Total liabilities

    $180.70K
    ESLAW annual total liabilities is $180.70 thousand

    Long term liabilities

    $0.00
    ESLAW annual total long term liabilities is $0.00

    Current liabilities

    $180.70K
    ESLAW annual total current liabilities is $180.70 thousand

    Accounts payable

    $0.00
    ESLAW annual accounts payable is $0.00

    Debt

    Total debt

    -
    ESLAW annual total debt value is unknown

    Total debt 1-year change

    -
    ESLAW annual total debt 1-year change is unknown

    Long term debt

    -
    ESLAW annual long term debt value is unknown

    Short term debt

    -
    ESLAW annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $4.27M
    ESLAW annual stockholders equity is $4.27 million

    Book value

    $4.27M
    ESLAW annual book value is $4.27 million

    Retained earnings

    -$19.50M
    ESLAW annual retained earnings is -$19.50 million

    Working capital

    $4.27M
    ESLAW annual working capital is $4.27 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$16.07M
    ESLAW annual cash flow from operations is -$16.07 million

    Cash from operations 1-year change

    -1102.61%
    ESLAW annual cash flow from operations is down -1102.61% year-on-year

    Cash from investing

    $4.96M
    ESLAW annual cash flow from investing activities is $4.96 million

    Cash from investing 1-year change

    +1916.65%
    ESLAW annual cash flow from investing activities is up +1916.65% year-on-year

    Cash from financing

    $12.79M
    ESLAW annual cash flow from financing activities is $12.79 million

    Cash from financing 1-year change

    +100%
    ESLAW annual cash flow from financing activities is up +100% year-on-year

    CAPEX

    CAPEX

    -
    ESLAW annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ESLAW annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$16.07M
    ESLAW annual free cash flow is -$16.07 million

    Free cash flow 1-year change

    -1102.61%
    ESLAW annual free cash flow is down -1102.61% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ESLAW annual gross profit margin value is unknown

    Operating margin

    -
    ESLAW annual operating profit margin value is unknown

    Net margin

    -
    ESLAW annual net profit margin value is unknown

    ROA & ROE

    ROA

    -164.15%
    ESLAW annual return on assets is -164.15%

    ROE

    -171.09%
    ESLAW annual return on equity is -171.09%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ESLAW price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ESLAW price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    ESLAW price to book ratio value is unknown

    PB ratio Sector rank

    -
    ESLAW price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    ESLAW price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ESLAW price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    ESLAW enterprise value value is unknown

    Enterprise value Sector rank

    -
    ESLAW enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    ESLAW EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    ESLAW EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    24.65
    ESLAW annual current ratio is 24.65

    Quick ratio

    -
    ESLAW annual quick ratio value is unknown

    Leverage

    Debt to equity

    -
    ESLAW annual debt to equity ratio value is unknown

    Interest coverage ratio

    -
    ESLAW annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ESLAW piotroski f-score value is unknown

    Altman Z-Score

    -
    ESLAW altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with ESLAW included

    No data
    • What is the ticker symbol for Estrella Immunopharma?
    • Does Estrella Immunopharma pay dividends?
    • What sector is Estrella Immunopharma in?
    • What industry is Estrella Immunopharma in?
    • What country is Estrella Immunopharma based in?
    • Is Estrella Immunopharma in the S&P 500?
    • Is Estrella Immunopharma in the NASDAQ 100?
    • Is Estrella Immunopharma in the Dow Jones?
    • When does Estrella Immunopharma report earnings?

    What is the ticker symbol for Estrella Immunopharma?

    The ticker symbol for Estrella Immunopharma is NASDAQ:ESLAW

    Does Estrella Immunopharma pay dividends?

    No, Estrella Immunopharma does not pay dividends

    What sector is Estrella Immunopharma in?

    Estrella Immunopharma is in the Healthcare sector

    What industry is Estrella Immunopharma in?

    Estrella Immunopharma is in the Biotechnology industry

    What country is Estrella Immunopharma based in?

    Estrella Immunopharma is headquartered in United States

    Is Estrella Immunopharma in the S&P 500?

    No, Estrella Immunopharma is not included in the S&P 500 index

    Is Estrella Immunopharma in the NASDAQ 100?

    No, Estrella Immunopharma is not included in the NASDAQ 100 index

    Is Estrella Immunopharma in the Dow Jones?

    No, Estrella Immunopharma is not included in the Dow Jones index

    When does Estrella Immunopharma report earnings?

    The date for Estrella Immunopharma's next earnings report has not been announced yet
    On this page